For thirty-four years, the symposium’s mission has been to provide state-of-the-art information on breast cancer research.  From a one-day regional conference the symposium has grown to a five-day program attended by a broad international audience of academic and private researchers and physicians from over 90 countries.

The symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication, and education for a broad spectrum of researchers, health professionals, and those with a special interest in breast cancer.

In 2007, the Cancer Therapy & Research Center (CTRC) at UT Health Science Center San Antonio and the American Association for Cancer Research (AACR) announced a collaboration for the future of the San Antonio Breast Cancer Symposium.  The symposium has been renamed the CTRC-AACR San Antonio Breast Cancer Symposium.  Complementing the clinical strengths of the highly regarded annual San Antonio Breast Cancer Symposium, the AACR's scientific prestige in basic, translational and clinical cancer research will create a unique and comprehensive scientific meeting that will advance breast cancer research for the benefit of patients.

In 2005, Baylor College of Medicine became a joint sponsor of the symposium and will remain in the CTRC-AACR collaboration.

C. Kent Osborne, MD, Professor of Medicine and Molecular and Cellular Biology, Director, Dan L. Duncan Cancer Center, Director, Breast Center, Baylor College of Medicine, Peter M. Ravdin, MD, PhD, Director of the Breast Cancer Program, UT Health Science Center San Antonio and Carlos L. Arteaga, MD, Director, Breast Cancer Program Vanderbilt-Ingram Cancer Center, Vanderbilt University are Co-Directors of the symposium.

This symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease to an international audience of academic and private physicians and researchers.

This international symposium is directed primarily towards academic and private physicians and researchers involved in breast cancer in medical, surgical, gynecologic, and radiation oncology, as well as other appropriate health care professionals.

Individuals searching for breast cancer treatment information, help line, support groups, etc., please visit the website of Susan G. Komen for the Cure at www.komen.org.

All administrative functions of the San Antonio Breast Cancer Symposium occur in the symposium operations office, which is located at Cancer Therapy & Research Center, 7979 Wurzbach, San Antonio, Texas 78229.

Co-Directors

C. Kent Osborne, MD, Professor of Medicine and Molecular and Cellular Biology, Director, Dan L. Duncan Cancer Center, Director, Breast Center, Baylor College of Medicine, Houston, Texas, USA

Peter M. Ravdin, MD, PhD, Director of the Breast Cancer Program, UT Health Science Center San Antonio, San Antonio, Texas, USA

Carlos L. Arteaga, MD, Director, Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, USA

Charles A. Coltman, Jr., Ex-Officio, UT Health Science Center San Antonio, San Antonio, TX

Executive Committee

Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN
Gary C. Chamness, Baylor College of Medicine, Houston, TX
Margaret Foti, American Association for Cancer Research, Philadelphia, PA

Suzanne A.W. Fuqua, Baylor College of Medicine, Houston, TX

Ismail Jatoi, UT Health Science Center, San Antonio, TX

C. Kent Osborne, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX

Peter M. Ravdin, MD, PhD, UT Health Science Center, San Antonio, TX
Saraswati Sukumar, Johns Hopkins University School of Medicine, Baltimore, MD

Ian Thompson, UT Health Science Center, San Antonio, TX

Program Coordinator

Gary C. Chamness, Baylor College of Medicine, Houston, TX

Director, Symposia

Rich Markow, UT Health Science Center, San Antonio, TX

The majority of participants are physicians and researchers, with smaller representation by affiliated health care professionals. The 2010 audience was composed of 49% medical doctors and 9% basic research scientists. Registrations totaled 7,913 and 93 countries (including US and Canada) were represented.

Henry B. Gonzalez Convention Center, 200 E. Market Street, San Antonio, Texas 78205, is the meeting site.

• December 4-8, 2012
• December 10-14, 2013
• December 9-13, 2014

Mr. Rich Markow, Director, Symposia
Cancer Therapy & Research Center at UT Health Science Center San Antonio

7979 Wurzbach Road, MC 8224

San Antonio, TX 78229
210-450-1550
210-450-1560 FAX
Email: sabcs@uthscsa.edu
Website Address: www.sabcs.org

The First Annual San Antonio Breast Cancer Symposium was held November 11, 1978 during Breast Cancer Awareness Week, and was part of an intensive 3-year outreach program of public and professional education designed to significantly reduce the death rate caused by breast cancer in San Antonio and surrounding counties. It was sponsored by Cancer Therapy and Research Center (CTRC) and the American Cancer Society, Texas Division, in conjunction with The University of Texas Health Science Center at San Antonio (UTHSCSA) and the Bexar County Medical Society. That all-day course for physicians and surgeons was organized and co-directed by Charles A. Coltman, Jr., MD and William L. McGuire, MD, both Professors of Medicine at UTHSCSA. It featured invited presentations by a panel of internationally known specialists and was attended by 141 physicians and surgeons from a 5-state area. Three years later, in 1981, the meeting was expanded to two days, a call for abstracts was distributed worldwide, and proffered papers for slide and poster presentations were incorporated into the program, thereby broadening its scope to both attract and draw from a larger, international base. Renowned experts gave formal plenary lectures, and accepted abstracts were published for the first time in the peer-reviewed journal Breast Cancer Research and Treatment. Case discussion lunches offered opportunity for discussion of complex clinical problems in the management of primary and metastatic disease, by a panel of physicians from different disciplines.

Although some modifications have been made in the format, such as incorporating pre-symposium educational sessions, Year In Review and lunchtime forums the overall format remains very much
the same. This reflects the objective of the Symposium, which is to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

In 1990, CTRC and UTHSCSA formally entered into a collaboration known as the San Antonio Cancer Institute (an NCI designated Comprehensive Cancer Center), which in 1995 assumed direct sponsorship of the Symposium. In 1992, C. Kent Osborne, MD became Co-Director of the symposium upon the death of William L. McGuire, MD. In 1999, C. Kent Osborne, MD, Co-Director of the symposium left UTHSCSA and opened the Breast Center at Baylor College of Medicine. In 2005, Baylor College of Medicine became a joint sponsor of the symposium. In 2008 the American Association for Cancer Research became a joint sponsor of the symposium. Through the efforts of UTHSCSA, AACR and BCM, the program attracts more thought-leaders and high-quality proffered papers in basic and translational breast cancer research as well as increasing the participation of young investigators by providing superior education and training opportunities for the next generation of breast cancer researchers.

The driving force behind the collaboration is the shared mission of the partners to advance progress against breast cancer. By combining their respective strengths, the partnership will produce a scientific meeting that encompasses the full spectrum of breast cancer research, facilitating the rapid translation of new knowledge into better care for breast cancer patients.

In 2010 Peter M. Ravdin, MD, PhD, Director of the Breast Cancer Program at the Cancer Therapy & Research Center at UT Health Science Center assumed the role of Co-Director of the symposium
upon the retirement of Charles A. Coltman, Jr, MD. Dr. Coltman remains Co-Director, ex-officio.

In 2011 Carlos L. Arteaga, Professor of medicine and Cancer Biology, Interim Director, Division of Hematology-Oncology, Director, Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University was appointed Co-Director of the symposium representing American Association for Cancer Research.

The UT Health Science Center San Antonio School of Medicine, through the Office of Continuing Medical Education, continues to be the provider of CME sponsorship for this premier breast cancer symposium.

All administrative functions are the responsibility of the Symposia Director and occur in the Symposium operations office, which is located at Cancer Therapy & Research Center, 7979 Wurzbach, San Antonio, Texas 78229. All proceeds from registration and abstract fees, industry educational grants, and exhibit fees, are used for Symposium development and operations, and for support of its staff which consists of the Symposia Director, the Senior Meeting Planner, the Meeting Planner and the Administrative Assistant.

Dr. William L. McGuire, along with Dr. Charles A. Coltman, founded the San Antonio Breast Cancer Symposium in 1977.  The William L. McGuire Memorial Lectureship was established in 1992 to commemorate the significant contributions of Dr. McGuire to oncology medicine. His research played a major role in introducing estrogen receptor assays on breast tumor tissue as a guide to treatment decisions for women with breast cancer. Breast cancer patients everywhere now receive these tests.

The award recipients since 1992 are:

Year	William L. McGuire Memorial Lecture
1992	Marc Lippman, MD
1993	Bernard Fisher, MD
1994	Craig Jordan, PhD, DSc
1995	Bert O’Malley, MD
1996	Benita S. Katzenellenbogen, PhD
1997	Kathryn Bloch Horwitz, PhD
1998	C. Kent Osborne, MD
1999	Charles A. Coltman, Jr., MD
2000	Trevor J. Powles, MD PhD
2001	Nancy E. Davidson, MD
2002	Michael Baum, MD
2003	Umberto Veronesi, MD
2004	Amy S. Langer, MBA
2005	Dennis J. Slamon, MD, PhD
2006	Richard J. Santen, MD
2007	Mitchell Dowsett, PhD
2008	Larry Norton, MD
2009	Martine Piccart, MD, PhD
2010	George W. Sledge, Jr., MD

 

AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure® is presented to an investigator no more than 50 years of age whose novel and significant work that has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment, or prevention of breast cancer.

AACR Distinguished Lectureship in Breast Cancer Research

The AACR Distinguished Lectureship in Breast Cancer Research has been established to recognize outstanding science that has inspired or has the potential to inspire new perspectives on the etiology, diagnosis, treatment, or prevention of breast cancer.

The award recipients since 2008 are:

In 2010, registrants from the following countries participated.